Memphasys Limited (MEM.AX)

AUD 0.01

(0.0%)

Long Term Debt Summary of Memphasys Limited

  • Memphasys Limited's latest annual long term debt in 2024 was - AUD , down 0.0% from previous year.
  • Memphasys Limited's latest quarterly long term debt in 2024 FY was - AUD , down -100.0% from previous quarter.
  • Memphasys Limited reported annual long term debt of 1.71 Million AUD in 2023, up 2117.13% from previous year.
  • Memphasys Limited reported annual long term debt of 77.33 Thousand AUD in 2022, down -97.56% from previous year.
  • Memphasys Limited reported quarterly long term debt of 1.65 Million AUD for 2024 Q2, down 0.0% from previous quarter.
  • Memphasys Limited reported quarterly long term debt of - AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Memphasys Limited (2024 - 2008)

Historical Annual Long Term Debt of Memphasys Limited (2024 - 2008)

Year Long Term Debt Long Term Debt Growth
2024 - AUD 0.0%
2023 1.71 Million AUD 2117.13%
2022 77.33 Thousand AUD -97.56%
2021 3.16 Million AUD 239.87%
2020 931.05 Thousand AUD 31195.9%
2019 2975.00 AUD -55.9%
2018 6746.00 AUD -99.33%
2017 1.01 Million AUD 3345.67%
2016 29.35 Thousand AUD -98.95%
2015 2.78 Million AUD -55.34%
2014 6.23 Million AUD 297.68%
2013 1.56 Million AUD 0.0%
2012 - AUD -100.0%
2011 377.28 Thousand AUD 0.0%
2010 - AUD -100.0%
2009 401.8 Thousand AUD -70.39%
2008 1.35 Million AUD 0.0%

Peer Long Term Debt Comparison of Memphasys Limited

Name Long Term Debt Long Term Debt Difference
AdAlta Limited 1.08 Million AUD 100.0%
Acrux Limited - AUD NaN%
Amplia Therapeutics Limited 13.89 Thousand AUD 100.0%
Biome Australia Limited - AUD NaN%
BTC Health Limited - AUD NaN%
Chimeric Therapeutics Limited - AUD NaN%
CSL Limited 14.48 Billion AUD 100.0%
Clarity Pharmaceuticals Ltd - AUD NaN%
Clinuvel Pharmaceuticals Limited 509.92 Thousand AUD 100.0%
Noxopharm Limited - AUD NaN%
PharmAust Limited - AUD NaN%
Proteomics International Laboratories Limited 221.03 Thousand AUD 100.0%
Prescient Therapeutics Limited - AUD NaN%
PYC Therapeutics Limited - AUD NaN%
Race Oncology Limited - AUD NaN%
Starpharma Holdings Limited 1.95 Million AUD 100.0%
EZZ Life Science Holdings Limited - AUD NaN%
Botanix Pharmaceuticals Limited - AUD NaN%
Nyrada Inc. - AUD NaN%
Anatara Lifesciences Ltd - AUD NaN%
Telix Pharmaceuticals Limited 15.88 Million AUD 100.0%
Bio-Gene Technology Limited - AUD NaN%
Zelira Therapeutics Limited 2.11 Million AUD 100.0%
Patrys Limited - AUD NaN%
Dimerix Limited 69.51 Thousand AUD 100.0%
Neuren Pharmaceuticals Limited - AUD NaN%
Orthocell Limited 540.72 Thousand AUD 100.0%
Imugene Limited - AUD NaN%
Cynata Therapeutics Limited - AUD NaN%
Immutep Limited 1.04 Million AUD 100.0%
Arovella Therapeutics Limited - AUD NaN%
Alterity Therapeutics Limited 51.91 Thousand AUD 100.0%
Nanollose Limited - AUD NaN%
Invex Therapeutics Ltd - AUD NaN%
NeuroScientific Biopharmaceuticals Limited - AUD NaN%
Island Pharmaceuticals Limited - AUD NaN%
Biotron Limited - AUD NaN%
Radiopharm Theranostics Limited - AUD NaN%
Tissue Repair Ltd - AUD NaN%
AnteoTech Limited 19.22 Thousand AUD 100.0%
Hexima Limited - AUD NaN%
Paradigm Biopharmaceuticals Limited 117.48 Thousand AUD 100.0%
Recce Pharmaceuticals Ltd 587.1 Thousand AUD 100.0%
Avecho Biotechnology Limited 98.22 Thousand AUD 100.0%
Actinogen Medical Limited - AUD NaN%
Immuron Limited 132.94 Thousand AUD 100.0%
Argenica Therapeutics Limited - AUD NaN%